The Queen Mary University of London professor leading an international breast cancer study says anastrozole - rather than tamoxifen - should be the preventive drug-of-choice for post-menopausal women ...
Share on Pinterest Anastrozole can reduce breast cancer risk after menopause, but does it come with its own risks? Image credit: shironosov/Getty Images. A drug used as a breast cancer treatment has ...
The Queen Mary University of London professor leading an international breast cancer study says anastrozole - rather than tamoxifen - should be the preventive drug-of-choice for post-menopausal women ...
A drug previously used to treat breast cancer is now being offered to high risk women as a preventative measure. It has previously been used to treat breast cancer but has been “repurposed” to prevent ...
Women with a high risk for breast cancer can cut their chances of developing the disease by 53% with the drug anastrozole after five years during a study. The finding, published in the journal the ...
SAN ANTONIO — Anastrozole reduced breast cancer risk by 49% compared with placebo for postmenopausal women at high risk for the disease, according to long-term results of the randomized controlled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback